Discover 928 paid clinical trials in Portland, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 928
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
for
Breast Cancer, Solid Tumors, Adult
Location: Portland OR, San Francisco CA, West Valley City UT,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT05768139
Phase 1, Phase 2, Recruiting
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma
for
Melanoma, Cutaneous Malignant, Mucosal Melanoma
Location: Portland OR, Seattle WA, Vancouver, San Francisco CA,
Sponsor: Immatics US, Inc.
Sex: All
Age: 18+
Code: NCT06743126
Phase 3, Recruiting
Intratumoral CAN1012(Selective TLR7 Agonist) in Subjects With Solid Tumors
for
Solid Tumor, Cancer Metastatic
Location: Portland OR, Woburn MA
Sponsor: CanWell Pharma Inc.
Sex: All
Age: 18 - 70+
Code: NCT04987112
Phase 1, Recruiting
The Lilac Device Trial - IMPACT: A Clinical Investigation on IMproving Peripheral Neuropathy Induced by Chemotherapy With Advanced Compression Technology - A Safety and Efficacy Study
for
Chemotherapy Induced Peripheral Neuropathy (CIPN)
Location: Portland OR, Minneapolis MN, Green Bay WI, Hinsdale IL,
Sponsor: Luminate Medical, Inc.
Sex: All
Age: 18+
Code: NCT07142304
Recruiting
First in Human Study of CDR404 in HLA-A*02:01 Participants With MAGE-A4 Expressing Solid Tumors
for
Select Advanced Solid Tumors
Location: Portland OR, Philadelphia PA
Sponsor: CDR-Life AG
Sex: All
Age: 18+
Code: NCT06402201
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors
for
Advanced or Metastatic Solid Tumors
Location: Portland OR, Santa Monica CA, Irving TX, San Antonio TX,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT07205718
Phase 1, Phase 2, Recruiting
A Study of Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants With Resectable EGFR-Mutated NSCLC
for
Carcinoma, Non-Small-Cell Lung
Location: Portland OR, Stanford CA, Duarte CA, Irvine CA, Toronto,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07586202
Phase 2, Recruiting
A Clinical Study of YL205 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Portland OR, Seattle WA, Las Vegas NV, Albuquerque NM,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Sex: All
Age: 18+
Code: NCT06459973
Phase 1, Phase 2, Recruiting
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
for
Small Cell Lung Cancer Metastatic or Locally Advanced,
Location: Portland OR, Seattle WA, San Francisco CA, Glendale CA,
Sponsor: SystImmune Inc.
Sex: All
Age: 18+
Code: NCT07080242
Phase 1, Recruiting
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Portland OR, Seattle WA, Los Angeles CA, La Jolla CA,
Sponsor: Regeneron Pharmaceuticals
Sex: Female
Age: 18+
Code: NCT06787612
Phase 2, Recruiting
A Clinical Trial to Evaluate the Safety, Tolerability and Clinical Efficacy of M3T01 Monotherapy and in Combination With Pembrolizumab and Other Systemic Therapies
for
Advanced Solid Tumors
Location: Portland OR
Sponsor: Providence Health & Services
Sex: All
Age: 18+
Code: NCT06719362
Phase 1, Recruiting
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
for
Small Cell Lung Cancer Extensive Stage
Location: Portland OR, Santa Rosa CA, Aurora CO, Sioux Falls SD,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07227597
Phase 1, Phase 2, Recruiting
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
for
Non-small Cell Lung Cancer
Location: Portland OR, Reno NV, Roseville CA, San Francisco CA,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07195695
Phase 3, Recruiting
Neoadjuvant INBRX-106 in Combination With Pembrolizumab for Stage II/III TNBC Patients
for
Triple Negative Breast Cancer
Location: Portland OR, Los Angeles CA
Sponsor: Providence Health & Services
Sex: All
Age: 18+
Code: NCT06353997
Phase 2, Recruiting
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
for
Advanced Breast Cancer
Location: Portland OR, San Francisco CA, Palo Alto CA,
Sponsor: Stemline Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06638307
Phase 1, Recruiting
A Phase 1/1b Study of IAM1363 in HER2 Cancers
for
HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer,
Location: Portland OR, Seattle WA, West Valley City UT,
Sponsor: Iambic Therapeutics, Inc
Sex: All
Age: 18+
Code: NCT06253871
Phase 1, Recruiting
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
for
Carcinoma, Non-Small Cell Lung,
Location: Portland OR, Olympia WA, Tacoma WA, Seattle WA,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All
Age: 18+
Code: NCT04389632
Phase 1, Recruiting
Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
for
Kidney Cancer
Location: Portland OR, Los Angeles CA, Maywood IL,
Sponsor: Jonsson Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT00301990
Phase 2, Recruiting
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
for
Cervical Cancer
Location: Portland OR, Reno NV, Palo Alto CA, Los Angeles CA,